The North America Cardiac Safety Services Market would witness market growth of 10.3% CAGR during the forecast period (2022-2028).
Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of these deaths happen before the age of 70. The majority of CVD fatalities occur in low- and middle-income nations. For counseling and medication to be used in cardiovascular disease treatment, early identification is essential.
The primary behavioral risk factors for heart disordersand stroke include poor eating habits, inactivity, cigarette use, and alcohol abuse. As a result of behavioral risk factors, people may develop high blood pressure, high blood sugar, and high blood lipids, along with overweight and obesity. These 'intermediate risk variables'indicate an enhanced chance of outcomes like heart attack, stroke, and heart failure and can be examined in primary care settings.
It has been demonstrated that reducing the risk of cardiovascular disease involves quitting smoking, cutting back on salt intake, eating more fruits and vegetables, engaging in regular physical activity, and abstaining from problematic alcohol consumption. Health policies that support environments where healthy choices are both accessible and affordable are essential if people are to acquire and maintain healthy behaviors.
As per the Pan American Heart Organization (PAHO) in the North American region, 40.8 million disability-adjusted life years (DALYs) are caused each year by cardiovascular illnesses. 89% of all CVD DALYs were caused by premature deaths, which resulted in 36.4 million years of life lost (YLLs). Years with disability (YLDs) accounted for 4.5 million. Because of population expansion and aging, it is probable that the overall number of CVD fatalities and YLDs will rise. The two primary underlying conditions that contribute to CVD death and disability are ischemic heart disease and stroke.
The US market dominated the North America Cardiac Safety Services Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $290.8 Million by 2028. The Canada market is poised to grow at a CAGR of 12.9% during (2022-2028). Additionally, The Mexico market would witness a CAGR of 11.9% during (2022-2028).
Based on Type, the market is segmented into Integrated and Standalone. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies and Contract Research Organizations. Based on Type of Service, the market is segmented into ECG/Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Clario, IQVIA Holdings, Inc., Laboratory Corporation of America Holdings, Pharmaceutical Product Development, Inc., SGS S.A., Banook Group, Biotrial Research SAS, Certara, Inc., and Celerion.
Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of these deaths happen before the age of 70. The majority of CVD fatalities occur in low- and middle-income nations. For counseling and medication to be used in cardiovascular disease treatment, early identification is essential.
The primary behavioral risk factors for heart disordersand stroke include poor eating habits, inactivity, cigarette use, and alcohol abuse. As a result of behavioral risk factors, people may develop high blood pressure, high blood sugar, and high blood lipids, along with overweight and obesity. These 'intermediate risk variables'indicate an enhanced chance of outcomes like heart attack, stroke, and heart failure and can be examined in primary care settings.
It has been demonstrated that reducing the risk of cardiovascular disease involves quitting smoking, cutting back on salt intake, eating more fruits and vegetables, engaging in regular physical activity, and abstaining from problematic alcohol consumption. Health policies that support environments where healthy choices are both accessible and affordable are essential if people are to acquire and maintain healthy behaviors.
As per the Pan American Heart Organization (PAHO) in the North American region, 40.8 million disability-adjusted life years (DALYs) are caused each year by cardiovascular illnesses. 89% of all CVD DALYs were caused by premature deaths, which resulted in 36.4 million years of life lost (YLLs). Years with disability (YLDs) accounted for 4.5 million. Because of population expansion and aging, it is probable that the overall number of CVD fatalities and YLDs will rise. The two primary underlying conditions that contribute to CVD death and disability are ischemic heart disease and stroke.
The US market dominated the North America Cardiac Safety Services Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $290.8 Million by 2028. The Canada market is poised to grow at a CAGR of 12.9% during (2022-2028). Additionally, The Mexico market would witness a CAGR of 11.9% during (2022-2028).
Based on Type, the market is segmented into Integrated and Standalone. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies and Contract Research Organizations. Based on Type of Service, the market is segmented into ECG/Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Studies, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Clario, IQVIA Holdings, Inc., Laboratory Corporation of America Holdings, Pharmaceutical Product Development, Inc., SGS S.A., Banook Group, Biotrial Research SAS, Certara, Inc., and Celerion.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Integrated
- Standalone
By End User
- Pharmaceutical & Biopharmaceutical Companies
- Contract Research Organizations
By Type of Service
- ECG/Holter Measurement
- Blood Pressure Measurement
- Cardiovascular Imaging
- Thorough QT Studies
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Koninklijke Philips N.V.
- Clario
- IQVIA Holdings, Inc.
- Laboratory Corporation of America Holdings
- Pharmaceutical Product Development, Inc.
- SGS S.A.
- Banook Group
- Biotrial Research SAS
- Certara, Inc.
- Celerion
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. North America Cardiac Safety Services Market by Type
Chapter 5. North America Cardiac Safety Services Market by End User
Chapter 6. North America Cardiac Safety Services Market by Type of Service
Chapter 7. North America Cardiac Safety Services Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Koninklijke Philips N.V.
- Clario
- IQVIA Holdings, Inc.
- Laboratory Corporation of America Holdings
- Pharmaceutical Product Development, Inc.
- SGS S.A.
- Banook Group
- Biotrial Research SAS
- Certara, Inc.
- Celerion
Methodology
LOADING...
